Company / Operating Cash Flow per Share
Thermo Fisher Scientific Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$20.15
FY2025
5-year range
$12.34 / $23.46
FY2021-FY2025
Trend
-8.4%
vs FY2024
Sector context
#11 of 161
Health Care
What the data says
Among 161 Health Care companies, Thermo Fisher Scientific is in the top 7% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $8.10 in FY2016 to $23.46 in FY2023.
Based on SEC 10-K filings.
20.15 in FY2025 with a 5-year CAGR of -0.3%. Top quartile in the Health Care sector.
Declined from $23.46 to $20.15 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 161This company $20.15 Sector average $6.67
▼
+202.1% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 8.4% year-over-year.
- Ranks #11 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2016.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.15 | -8.4% |
| FY2024 | $22.00 | -6.2% |
| FY2023 | $23.46 | +12.9% |
| FY2022 | $20.77 | +68.4% |
| FY2021 | $12.34 | -39.6% |
| FY2020 | $20.42 | +63.4% |
| FY2019 | $12.49 | +9.2% |
| FY2018 | $11.44 | +14.9% |
| FY2017 | $9.96 | +23.0% |
| FY2016 | $8.10 | +0.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026